※この記事は生成AIで翻訳しています。内容の解釈は原文を優先してください。 この記事のポイント 糖尿病や肥満の治療薬であるGLP-1受容体作動薬（GLP-1 RA）と、新生血管加齢黄斑変性（nAMD）発症リスクの関連を調査した。 糖尿病患者の大規模コホート ...

New research examined the effects of cataract surgery on visual acuity and disease activity in patients with nAMD receiving anti-VEGF treatment. The treatment intensity for underlying nAMD remained ...

50歳以上の滲出型加齢黄斑変性（nAMD）による脈絡膜新生血管（CNV）患者18例を対象に、二重特異性融合タンパク質efdamrofusp alfa硝子体内投与の安全性、忍容性および有効性を無作為化第Ib相試験で検討。患者をefdamrofusp alfaの2mg群、4mg群、アフリベルセプト2mg群 ...

In AVONELLE-X, the largest long-term extension trial in nAMD, disease control and durability were maintained over 4 years, with nearly 80% of patients on extended dosing by study end 1 Over 60% of ...

BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere to treatment than those who ...

Basel, 05 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new data from the AVONELLE-X and SALWEEN studies of Vabysmo® (faricimab),1,2 presented at the 25th Euretina Congress in ...